Skip to content Skip to navigation

Nir Barzilai

Nir Barzilai

Nir Barzilai

Director of the Institute for Aging Research, the Paul F. Glenn Center for the Biology of Human Aging Research and of the NIH Nathan Shock Centers of Excellence in the Basic Biology of Aging
Ingeborg and Ira Leon Rennert Chair in Aging Research and Professor, Department of Medicine (Endocrinology) and Genetics at Einstein College of Medicine, New York

Nir Barzilai, M.D. is director of the Institute for Aging Research, the Paul F. Glenn Center for the Biology of Human Aging Research and of the NIH Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is Ingeborg and Ira Leon Rennert Chair in Aging Research and Professor, Department of Medicine (Endocrinology) and Genetics at Einstein College of Medicine, New York. He is known for pioneering work in identifying first human "longevity gene" and in the study of resilience mechanisms in centenarians, as well as his leading effort in the first clinical trial targeting aging with the diabetes drug Metformin (TAME) in humans.